Use of factor-analyzed symptom dimensions to predict outcome with serotonin reuptake inhibitors and placebo in the treatment of obsessive- compulsive disorder

American Journal of Psychiatry

Volumn 156, Issue 9, 1999, Pages 1409-1416

  Mataix Cols, David ^a   Rauch, Scott L ^b   Manzo, Peter A ^b   Jenike, Michael A ^b   Baer, Lee ^b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CLOMIPRAMINE; FLUOXETINE; FLUVOXAMINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; COMPULSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSESSION; OUTCOMES RESEARCH; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AMBULATORY CARE; CLOMIPRAMINE; COMORBIDITY; CONTROLLED CLINICAL TRIALS; FACTOR ANALYSIS, STATISTICAL; FEMALE; FLUOXETINE; FLUVOXAMINE; HUMANS; MALE; MIDDLE AGED; OBSESSIVE-COMPULSIVE DISORDER; PERSONALITY INVENTORY; PLACEBO EFFECT; PLACEBOS; PROBABILITY; PSYCHIATRIC STATUS RATING SCALES; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; SEROTONIN UPTAKE INHIBITORS; SEVERITY OF ILLNESS INDEX; TIC DISORDERS; TREATMENT OUTCOME;

EID: 0032879338     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Goodman WK, Price LH, Rasmussen SA, Delgado PL, Heninger GR, Charney DS: Efficacy of fluvoxamine in obsessive-compulsive disorder: a double-blind comparison with placebo. Arch Gen Psychiatry 1989; 46:36-44
2. Stanley MA, Turner SM: Current status of pharmacological and behavioral treatment of obsessive-compulsive disorder. Behav Ther 1995; 26:163-186
3. Alarcón RD, Libb JW, Spitler D: A predictive study of obsessive-compulsive disorder response to clomipramine. J Clin Psychopharmacol 1993; 13:210-213
4. Ackerman DL, Greenland S, Bystrytsky A, Morgenstern H, Katz RJ: Predictors of treatment response in obsessive-compulsive disorder: multivariate analyses from a multicenter trial of clomipramine. J Clin Psychopharmacol 1994; 14:247-254
5. Ravizza L, Barzega G, Bellino S, Bogetto F, Maina G: Predictors of drug treatment response in obsessive-compulsive disorder. J Clin Psychiatry 1995; 56:368-373
6. Jenike MA, Baer L, Minichiello WE, Schwartz CE, Carey RJ Jr: Concomitant obsessive-compulsive disorder and schizotypal personality disorder. Am J Psychiatry 1986; 143:530-533
7. Minichiello WE, Baer L, Jenike MA: Schizotypal personality disorder: a poor prognostic indicator for behaviour therapy in the treatment ot obsessive compulsive disorder. J Anxiety Disorders 1987; 1:273-276
8. Baer L, Jenike MA, Black DW, Treece C, Rosenfeld R, Greist J: Effect of axis II diagnoses on treatment outcome with clomipramine in 55 patients with obsessive-compulsive disorder. Arch Gen Psychiatry 1992; 49:862-866
9. Jenike MA: Predictors of treatment failure, in Obsessive Compulsive Disorders: Theory and Management, 2nd ed. Edited by Jenike MA, Baer L, Minichiello WE. Chicago, Year Book Medical, 1990, pp 306-311
10. Dreessen L, Hoekstra R, Arntz A: Personality disorders do not influence the results of cognitive and behavior therapy for obsessive compulsive disorder. J Anxiety Disorders 1997; 11: 503-521
11. Rasmussen SA, Eisen JL: Clinical and epidemiological findings of significance to neuropharmacologic trials in obsessive-compulsive disorder. Psychopharmacol Bull 1988; 24: 466-470
12. McDougle CJ, Goodman, WK, Price LH: Dopamine antagonists in tic-related and psychotic spectrum obsessive compulsive disorder. J Clin Psychiatry 1994; 53(suppl 3):24-31
13. Jenike MA, Baer L, Minichiello WE, Rauch SL, Buttolph ML: Placebo-controlled trial of fluoxetine and phenelzine for obsessive-compulsive disorder. Am J Psychiatry 1997; 154: 1261-1264
14. Baer L, Rauch SL, Ballantine HT, Martuza R, Cosgrove R, Cassem E, Giriunas I, Manzo PA, Dimino C, Jenike MA: Cingulotomy for intractable obsessive compulsive disorder: prospective long-term follow-up of 18 patients. Arch Gen Psychiatry 1995; 52:384-392
15. Ball SG, Baer L, Otto MW: Symptom subtypes of obsessive-compulsive disorder in behavioral treatment studies: a quantitative review. Behav Res Ther 1996; 34:47-51
16. Rachman S, Hodgson RJ: Obsessions and Compulsions. Englewood Cliffs, NJ, Prentice-Hall, 1980
17. Buchanan AW, Ko SM, Marks IM: What predicts improvement and compliance during the behavioral treatment of obsessive compulsive disorder? Anxiety 1996; 2:22-27
18. Basoglu M, Lax T, Kasvikis Y, Marks IM: Predictors of improvement in obsessive compulsive disorder. J Anxiety Disorders 1988; 2:299-317
19. Foa EB, Goldstein A: Continuous exposure and complete response prevention in the treatment of obsessive-compulsive neurosis. Behavior Therapy 1978; 9:821-829
20. Baer L: Factor analysis of symptom subtypes of obsessive compulsive disorder and their relation to personality and tic disorders. J Clin Psychiatry 1994; 55(March suppl):18-23
21. Leckman JF, Grice DE, Boardman J, Zhang H, Vitale A, Bondi C, Alsobrook J, Peterson BS, Cohen DJ, Rasmussen SA, Goodman WK, McDougle CJ, Pauls DL: Symptoms of obsessive-compulsive disorder. Am J Psychiatry 1997; 154:911-917
22. Rauch SL, Dougherty DD, Shin LM, Alpert NM, Manzo P, Leahy L, Fischman AJ, Jenike MA, Baer L: Neural correlates of factor-analyzed OCD symptom dimensions: a PET study. CNS Spectrums 1998; 3(7):37-43
23. Jenike MA, Baer L, Summergrad P, Weilburg JB, Holland A, Seymour R: Obsessive-compulsive disorder: a double-blind, placebo-controlled trial of clomipramine in 27 patients. Am J Psychiatry 1989; 146:1328-1330
24. Jenike MA, Hyman S, Baer L, Holland A, Minichiello WE, Buttolph L, Summergrad P, Seymour R, Ricciardi J: A controlled trial of fluvoxamine in obsessive-compulsive disorder: implications for a serotonergic theory. Am J Psychiatry 1990; 147: 1209-1215
25. Tollefson GD, Rampey AH, Potvin JH, Jenike MA, Rush AJ, Dominguez RA, Koran LM, Shear MK, Goodman WK, Genduso LA: A multi-center investigation of fixed-dose fluoxetine in the treatment of obsessive-compulsive disorder. Arch Gen Psychiatry 1994; 51:559-567
26. Jenike MA, Baer L, Summergrad P, Minichiello WE, Holland A, Seymour R: Sertraline in obsessive-compulsive disorder: a double-blind comparison with placebo. Am J Psychiatry 1990; 147:923-928; correction, 147:1393
27. Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23:56-62
28. Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL, Heninger GR, Charney DS: The Yale-Brown Obsessive Compulsive Scale, I: development, use, and reliability. Arch Gen Psychiatry 1989; 46:1006-1011
29. Goodman WK, Price LH, Rasmussen SA, Mazure C, Delgado P, Heninger GR, Charney DS: The Yale-Brown Obsessive Compulsive Scale, II: validity. Arch Gen Psychiatry 1989; 46: 1012-1016
30. Insel TR, Murphy DL, Cohen RM, Alterman L, Kilts C, Linnoila M: Obsessive-compulsive disorder: a double-blind trial of clomipramine and clorgyline. Arch Gen Psychiatry 1983; 40: 605-612
31. Cohen J, Cohen P: Applied Multiple Regression/Correlation Analysis for the Behavioral Sciences, 2nd ed. Hillsdale, NJ, Lawrence Erlbaum Associates, 1983
32. Rasmussen SA, Eisen JL: Phenomenology of OCD: clinical subtypes, heterogeneity and coexistence, in The Psychobiology of Obsessive-Compulsive Disorder. Edited by Zohar J, Insel TR, Rasmussen SA. New York, Springer-Verlag, 1991, pp 13-43
33. Pitman RK, Green RC, Jenike MA, Mesulam MM: Clinical comparison of Tourette's disorder and obsessive-compulsive disorder. Am J Psychiatry 1987; 144:1166-1171
34. Holzer JC, Goodman WK, McDougle CJ, Baer L, Boyarsky BK, Leckman JF, Price LH: Obsessive compulsive disorder with and without a chronic tic disorder: a comparison of symptoms in 70 patients. Br J Psychiatry 1994; 164:469-473
35. Pitman RK: Pierre Janet on obsessive-compulsive disorder (1903): review and commentary. Arch Gen Psychiatry 1987; 44:226-232
36. Pauls DL, Alsobrook JP II, Goodman W, Rasmussen S, Leckman JF: A family study of obsessive-compulsive disorder. Am J Psychiatry 1995; 152:76-84
37. McDougle CJ, Goodman WK, Leckman JF, Barr LC, Heninger GR, Price LH: The efficacy of fluvoxamine in obsessive-compulsive disorder: effects of comorbid chronic tic disorder, J Clin Psychopharmacol 1993; 13:354-358
38. Swedo SE: Rituals and releasers: an ethological model of obsessive-compulsive disorder, in Obsessive Compulsive Disorder in Children and Adolescents. Edited by Rapoport JL. Washington, DC, American Psychiatric Press, 1989, pp 269-288
39. Shafran R, Talus F: Obsessive-compulsive hoarding: a cognitive-behavioural approach. Behavioural and Cognitive Psychotherapy 1996; 24:209-221
40. Hodgson RJ, Rachman S: Obsessional-compulsive complaints. Behav Res Ther 1977; 15:389-395
41. Baxter LR, Schwartz JM, Guze BH, Szuba MP: Neuroimaging in obsessive-compulsive disorder: seeking the mediating neuroanatomy, in Obsessive Compulsive Disorders: Theory and Management, 2nd ed. Edited by Jenike MA, Baer L, Minichiello WE. Chicago, Year Book Medical, 1990, pp 167-188
42. Alexander GE, DeLong MR, Stick PL: Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 1986; 9:357-381
43. Rettew DC, Swedo SE, Leonard HL, Lenane MC, Rapoport JL: Obsessions and compulsions across time in 79 children and adolescents with obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry 1992; 31:1050-1056